We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Ready Source of Functional Liver Cells Should Boost Drug Development Efforts

By LabMedica International staff writers
Posted on 09 Aug 2015
Print article
Image: Photomicrograph shows emergence of stem cell-derived hepatocytes (Photo courtesy of Dr. Yaakov Nahmias, Hebrew University of Jerusalem, Israel).
Image: Photomicrograph shows emergence of stem cell-derived hepatocytes (Photo courtesy of Dr. Yaakov Nahmias, Hebrew University of Jerusalem, Israel).
Liver function in newborns kicks in only after exposure to certain nutrient factors derived from gut bacteria, and this phenomenon has been used to differentiate pluripotent stem cells into fully functional liver cells (hepatocytes).

Investigators at the Hebrew University of Jerusalem (Israel) found that fetal hepatocytes acquired mature CYP450 (cytochrome P450) expression only after birth, suggesting that nutritional cues were required to drive hepatic maturation. Subsequently, they showed that vitamin K2 and lithocholic acid, a by-product of intestinal flora, activated pregnane X receptor (PXR) and CYP3A4 and CYP2C9 expression in isolated fetal hepatocytes.

Human pluripotent stem cells (hPSCs) represent an excellent source of differentiated hepatocytes; however, current protocols still produce fetal-like hepatocytes with limited mature function. In the current study, the investigators induced hPSCs to differentiate into fully functional mature hepatocytes by augmenting their growth medium with vitamin K2 and lithocholic acid.

They reported in the July 2015 issue of the journal Hepatology that differentiated cells produced albumin and apolipoprotein B100 at levels equivalent to primary human hepatocytes. Flow cytometry showed that over 83% of cells were albumin and hepatocyte nuclear factor 4 alpha (HNF4α) positive, which permitted high-content screening in a 96-well plate format. Stem cell–derived hepatocytes demonstrated all toxicological endpoints examined, including steatosis, apoptosis, and cholestasis, when exposed to nine known hepatotoxins.

“This is quite a revolution for pharmaceutical drug discovery,” said senior author Dr. Yaakov Nahmias, professor of bioengineering at the Hebrew University of Jerusalem. “While other groups have been able to produce liver cells before us, their cells showed little functional activity, and could not be reliably used for drug discovery. In fact, up until now stem cell-derived hepatocytes showed little ability to predict clinical outcome. The limited availability of functional hepatocytes for drug testing is a major bottleneck bringing pharmaceutical companies to spend USD one billion [per] year on liver cells alone. Our ability to produce an unlimited supply of functional liver cells from human pluripotent stem cells can change all that.”

Related Links:

Hebrew University of Jerusalem


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Cortisol Rapid Test
Finecare Cortisol Rapid Quantitative Test
New
Flow Cytometer
BF – 710

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The bowel cancer breakthrough could result in better treatment outcomes (Photo courtesy of 123RF)

New RNA Molecules Can Help Predict Bowel Cancer Return Recurrence

Colorectal cancer accounts for 10% of all cancer-related deaths worldwide and was ranked as the second most common cause of cancer death in the United States in 2022. Currently, clinicians face diagnostic... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image

AI-Based Method Shows Promise for Pathological Diagnosis of Hereditary Kidney Diseases

Alport syndrome is a hereditary kidney disorder characterized by kidney dysfunction, sensorineural hearing loss, and ocular abnormalities. Early in the disease, patients experience hematuria, which is... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.